Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides

被引：126

作者：

Lewczuk, P

Beck, G

Esselmann, H

Bruckmoser, R

Zimmermann, R

Fiszer, M

Bibl, M

Maler, JM

Kornhuber, J

Wiltfang, J

机构：

[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Mol Neurobiol Lab, D-91054 Erlangen, Germany

[2] Ctr Clin Neuroproteom, Erlangen, Germany

[3] Univ Gottingen, Dept Psychiat & Psychotherapy, D-3400 Gottingen, Germany

来源：

CLINICAL CHEMISTRY | 2006年 / 52卷 / 02期

关键词：

D O I：

10.1373/clinchem.2005.058776

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：332 / 334

页数：3

共 11 条

[1] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
Andreasen, N
Minthon, L
Davidsson, P
Vanmechelen, E
Vanderstichele, H
Winblad, B
Blennow, K
[J]. ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 373 - 379
[2] Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides
Bibl, M
Esselmann, H
Otto, M
Lewczuk, P
Cepek, L
Rüther, E
Kornhuber, J
Wiltfang, J
[J]. ELECTROPHORESIS, 2004, 25 (17) : 2912 - 2918
[3] High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
Galasko, D
Chang, L
Motter, R
Clark, CM
Kaye, J
Knopman, D
Thomas, R
Kholodenko, D
Schenk, D
Lieberburg, I
Miller, B
Green, R
Basherad, R
Kertiles, L
Boss, MA
Seubert, P
[J]. ARCHIVES OF NEUROLOGY, 1998, 55 (07) : 937 - 945
[4] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF
Hulstaert, F
Blennow, K
Ivanoiu, A
Schoonderwaldt, HC
Riemenschneider, M
De Deyn, PP
Bancher, C
Cras, P
Wiltfang, J
Mehta, PD
Iqbal, K
Pottel, H
Vanmechelen, E
Vanderstichele, H
[J]. NEUROLOGY, 1999, 52 (08) : 1555 - 1562
[5] Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
Lewczuk, P
Esselmann, H
Otto, M
Maler, JM
Henkel, AW
Henkel, MK
Eikenberg, O
Antz, C
Krause, WR
Reulbach, U
Kornhuber, J
Wiltfang, J
[J]. NEUROBIOLOGY OF AGING, 2004, 25 (03) : 273 - 281
[6] Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease - Original data and review of the literature
Lewczuk, P
Esselmann, H
Bibl, M
Beck, G
Maler, JM
Otto, M
Kornhuber, J
Wiltfang, L
[J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (1-2) : 115 - 122
[7] Effects of processing and storage conditions on amyloid β (1-42) and tau concentrations in cerebrospinal fluid:: Implications for use in clinical practice
Schoonenboom, NSM
Mulder, C
Vanderstichele, H
Van Elk, EJ
Kok, A
Van Kamp, GJ
Scheltens, P
Blankenstein, MA
[J]. CLINICAL CHEMISTRY, 2005, 51 (01) : 189 - 195
[8] Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
Vanderstichele, H
Van Kerschaver, E
Hesse, C
Davidsson, P
Buyse, MA
Andreasen, N
Minthon, L
Wallin, A
Blennow, K
Vanmechelen, E
[J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (04): : 245 - 258
[9] WILFANG J, 2002, J NEUROCHEM, V81, P481
[10] Elevation of β-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells
Wiltfang, J
Esselmann, H
Cupers, P
Neumann, M
Kretzschmar, H
Beyermann, M
Schleuder, D
Jahn, H
Rüther, E
Kornhuber, J
Annaert, W
De Strooper, B
Saftig, P
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) : 42645 - 42657

← 1 2 →